Lexaria Bioscience Corp.: Lexaria's DehydraTECH-CBD Achieves Superior Human Blood Absorption Levels
KELOWNA, BC / ACCESSWIRE / December 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it
Chris Bunka George Jurcic Exchange Commission Lexaria Bioscience Corp Lexaria Bioscience Corp View Company Or Lexaria
Source: finanznachrichten.de